COVID-19 rapid evidence summary: Tocilizumab for COVID-19 (ES33)
ES33 Product overview The content of this evidence summary was up to date in January 2021. See summaries of product characteristics
ES33 Product overview The content of this evidence summary was up to date in January 2021. See summaries of product characteristics
ES34 Product overview The content of this evidence summary was up to date in January 2021. See summaries of product characteristics